CI Platform
Sign in
Merdury Biopharmaceutical Corporation6932Unknown exchange
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

Unknown exchange

Company Overview

Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded on July 16, 2019 and is headquartered in New Taipei City. Taiwan.

Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded on July 16, 2019 and is headquartered in New Taipei City. Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryPharmaceutical Preparations
CountryTAIWAN
Employees19
Reporting UnitBillions
Primary ExchangeUnknown exchange
Instrument TypeEquity
Websitehttp://merdury.com
Wright IDC158KQ033

Key Metrics

Current price$5.99
Market cap$2.56 B
P/E ration/a
52-week perf.-15.5%
Common shares427.7 M
Share typeGu
Quality ratingDCD0
Dividend yield0.00%

Recent stock performance

1 Week+2.4%
4 Week-2.0%
13 Week+19.1%

Officers

n/a

Address

No653 Bannan Road Zhonghe District

NEW TAIPEI

TAIWAN

235

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.